We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$996K
Cap. Flow
+$5.81M
Cap. Flow %
4.86%
Top 10 Hldgs %
38.86%
Holding
79
New
17
Increased
26
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$3.24M
2
ALK icon
Alaska Air
ALK
+$2.41M
3
RPRX icon
Royalty Pharma
RPRX
+$2.19M
4
EG icon
Everest Group
EG
+$1.97M
5
HPQ icon
HP
HPQ
+$1.75M

Top Sells

Rank Stock Value
1
TGB
Trekor Metals
TGB
+$9.62M
2
FOLD
Amicus Therapeutics
FOLD
+$5.27M
3
PLPC icon
Preformed Line Products
PLPC
+$5.17M
4
CGAU
Centerra Gold
CGAU
+$2.87M
5
KDP icon
Keurig Dr Pepper
KDP
+$2.24M

Sector Composition

Rank Sector Weight
1 Healthcare 38.22%
2 Financials 12.92%
3 Technology 11.1%
4 Industrials 10%
5 Consumer Staples 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALCO icon
1
Alico
ALCO
$301M
$8.25M 6.9%
200,000
– –
RIGL icon
2
Rigel Pharmaceuticals
RIGL
$867M
$6.35M 5.31%
235,000
+10,000
+4% +$336K
RPRX icon
3
Royalty Pharma
RPRX
$27.1B
$6M 5.01%
125,000
+50,000
+67% +$2.19M
RLGT icon
4
Radiant Logistics
RLGT
$407M
$4.58M 3.83%
650,000
– –
INTT icon
5
inTEST
INTT
$142M
$4.5M 3.77%
330,000
-87,500
-21% -$959K
BGC icon
6
BGC Group
BGC
$5.75B
$4.4M 3.68%
450,000
+50,000
+13% +$463K
CHRS icon
7
Coherus Oncology
CHRS
$221M
$3.55M 2.97%
2,100,000
– –
CRL icon
8
Charles River Laboratories
CRL
$13.9B
$3.02M 2.52%
+17,500
New +$3.24M
HZO icon
9
MarineMax
HZO
$1.15B
$2.98M 2.49%
110,000
+10,000
+10% +$277K
NMRK icon
10
Newmark Group
NMRK
$2.87B
$2.85M 2.38%
190,000
– –
PK icon
11
Park Hotels & Resorts
PK
$3.19B
$2.63M 2.2%
250,000
+25,000
+11% +$276K
OGN icon
12
Organon & Co
OGN
$3.62B
$2.4M 2%
400,000
+200,000
+100% +$1.5M
VTRS icon
13
Viatris
VTRS
$18.7B
$2.36M 1.98%
175,000
-25,000
-13% -$350K
RBCAA icon
14
Republic Bancorp
RBCAA
$1.86B
$2.26M 1.89%
32,000
– –
ARKO icon
15
ARKO Corp
ARKO
$488M
$2.08M 1.74%
375,000
-25,000
-6% -$139K
ELDN icon
16
Eledon Pharmaceuticals
ELDN
$261M
$2M 1.67%
650,000
– –
EG icon
17
Everest Group
EG
$14.5B
$1.96M 1.64%
+6,000
New +$1.97M
AVIR icon
18
Atea Pharmaceuticals
AVIR
$430M
$1.91M 1.6%
355,000
– –
THFF icon
19
First Financial Corp
THFF
$941M
$1.9M 1.59%
30,000
+7,500
+33% +$477K
VTOL icon
20
Bristow Group
VTOL
$1.3B
$1.88M 1.57%
40,000
– –
ALK icon
21
Alaska Air
ALK
$4.73B
$1.84M 1.54%
+50,000
New +$2.41M
IOSP icon
22
Innospec
IOSP
$2.35B
$1.75M 1.47%
24,000
+4,000
+20% +$311K
HPQ icon
23
HP
HPQ
$27.4B
$1.73M 1.45%
+90,000
New +$1.75M
CPA icon
24
Copa Holdings
CPA
$5.3B
$1.7M 1.42%
15,000
+12,500
+500% +$1.64M
EOLS icon
25
Evolus
EOLS
$583M
$1.64M 1.37%
400,000
+150,000
+60% +$727K
1
2 3 4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q1 2026 Portfolio in Review

As of Q1 2026, CM Management held 79 positions worth $120M, up 0.84% from $119M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CM Management deployed $5.81M of net new capital in Q1 2026, opening 17 new positions and adding to 26 existing holdings. Its largest new stake was Charles River Laboratories: 17,500 shares worth $3.02M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 36% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $2.24M trimmed.

  • CM Management's largest Q1 2026 buy was Charles River Laboratories: 17,500 shares worth $3.02M.
  • CM Management added most to Royalty Pharma in Q1 2026, an estimated $2.19M increase.
  • CM Management's biggest Q1 2026 reduction was Keurig Dr Pepper, cutting an estimated $2.24M.
  • CM Management fully exited Trekor Metals in Q1 2026, selling an estimated $9.62M.
  • CM Management's ten largest holdings make up 39% of its $120M portfolio in Q1 2026.
  • CM Management opened 17 new positions and closed 8 in Q1 2026.
  • CM Management's portfolio value rose 0.84% quarter-over-quarter to $120M.

Based on CM Management's 13F filing for Q1 2026, filed 8 May 2026.